Projects

InOpSys

Sector
Circular Economy
Line of Business
Flexible and mobile units for wastewater treatment
Founders
AvOre (Steven De Laet) and Raf De Wil
Registered Office
12A Zandvoortstraat,
2800 Mechelen

InOpsys develops and builds flexible, modular and mobile units for onsite toxic wastewater treatment. This unique concept combines expertise, the use of existing and clean technologies as well as a new approach to waste management. In this way, InopSys helps chemical and pharmaceutical industries to reach their sustainable development goals.

The expertise comes from the KU Leuven, the technologies are acquired on the market or developed by AvoRe (one of the founders of InOpSys). The innovative approach consists of bringing the installation to the location where the water has to be treated by truck (Plant-On-A-Truck).

For more information: InOpSys

Innovation Fund Investment

On 18 December 2015, the Innovation Fund and Gemma Frisius invested EUR 500,000 each in InOpSys.

VMH (now PMV) joined the shareholders in September 2018 and provided further funding together with the existing shareholders.

Lisam

Sector
Processes, Information Technology
Line of Business
Management services for legal documents and reports on the environment, health and safety for different industrial sectors including chemistry.
Founders
Thierry Levintoff and Michel Hemberg
Registered Office
42A Boulevard de la Sennette,
7190 Ecausinnes

Combining a flexible technology that is easy to use, based on the Microsoft .NET platform with the latest regulatory content, Lisam provides innovative, affordable and rapid solutions to the environment, health and safety (EHS) challenges faced by manufacturers, distributors and users of chemical and cosmetic products.

In cooperation with the associations and partners from industry, Lisam has developed proprietary and vertical EHS solutions for chemicals, chemical speciality products, cosmetics, aromas, detergents, paints, coatings, plastics and the energy industries. Today, more than 900 customers in industry count on the Lisam flagship software, ExeSS®, to manage their safety datasheets and their labels, designed for all the main commercial markets and available in 50 languages.

For more information: Lisam

Innovation Fund Investment

On 28 January 2016, the Innovation Fund invested EUR 250,000 in LISAM.

PharmaFluidics – Sold to Thermo Fisher Scientific – November 1st, 2021

Sector
Processes – molecular separation and analysis
Line of Business
New generation liquid chromatography column
Founders
Paul Jacobs, Wim De Malssche, Gert Desmet and Joeri Denayer
Registered Office
Technologiepark, 3 Zwijnaarde,
9052 Zwijnaarde

PharmaFluidics is a spin-off of the Dutch-speaking Free University of Brussels (VUB) and has benefited from initial PMV/SOFI and Qbic financing to the tune of EUR 1.25 million.
The company has developed a new type of liquid chromatography columns (in the field of mixture separation and analysis) which shows a significant advantage compared to existing columns: ease of use, standardisation, efficacy and potential development to measure.

The company is refining these columns further, has obtained recommendations from laboratories and opinion leaders in the field, and markets them in the biotech, pharmaceutical and chemical industries.

For more information: PharmaFluidics

Innovation Fund Investment

On 9 May 2016, the Innovation Fund invested EUR 199,992 in PharmaFluidics. Further investments were made in 2017 and are expected going forward. The Fund’s stake in the capital is 5.6%

TrendMiner – Sold to Software AG – June 30th, 2018

Sector
Processes, Information Technology
Line of Business
Industrial process analysis, monitoring and prediction application
Founders
Bert Baeck, Noël Jans, Thomas Dhollander and Tom Coen
Registered Office
297 Kempische Steenweg B3,
B-3500 Hasselt

TrendMiner has developed an application which analyses and monitors in real time the temporal series of production parameters. TrendMiner is used to predict certain production anomalies by relying on the (predictive) recognition of historical patterns and search of similar historical patterns to help explain the causes of production deviances. TrendMiner “learns” by relying on parameters provided by the operator.

For more information: TrendMiner

Innovation Fund Investment

On 10 May 2016, the Innovation Fund decided to invest EUR 1,000,000 in TrendMiner.

X4C

Sector
Materials Technology
Line of Business
Application of a single layer in calix (4) arene for post-functionalisation.
Founders
Alice Mattiuzzi
Registered Office
Rue Auguste Piccard 48
6041 Gosselies

X4C has developed a new technology for applying a single layer on a substrate and for the post-functionalising of the substrate. This concept leads to a strong covalent bond between the substrate and the functional element.

The technology was developed in the organic chemistry laboratory of the Free University of Brussels under the direction of Professor Ivan Jabin.

For more information: X4C

Innovation Fund Investment

On 18 March 2016, the Innovation Fund decided to invest EUR 30,000 in X4C. This investment is contingent upon the finalisation of the licensing agreement with the Free University of Brussels. An additional investment is planned for 2017, depending on the results of the first commercial steps.

Fyteko

Sector
Biosciences
Line of Business
Development of a bio-stimulant to foster resistance to abiotic stress in crops
Founders
Juan Carlos Cabrera Pino, Guillaume Wegria
Registered Office
Allee de la Recherche 4
1070 Bruxelles
Belgium

Fyteko has discovered a molecule that induces better resistance to abiotic stress in a number of crops.

The scientific research was carried out by the founders.

For more information: Fyteko

Innovation Fund Investment

On September 29th, 2016, the Innovation Fund invested in Fyteko. The investment will help Fyteko register and market its first molecule while encouraging further research into formulation and molecules.

Mathym – Sold to Baikowski SA – September 30th, 2019

Sector
Materials Technology
Line of Business
Nanomaterials in colloidal solutions
Founders
Frederic Chaput, Julien Alberici
Registered Office
22 rue des Aulnes
69410 Champagne-au-Mont-d’Or
France

Mathym has developed a technology to produce easy and safe to use colloidal nanoparticles as ingredients in medical composite materials. The first products came on the market in 2017.

The underlying research was carried out by Frederic Chaput at ENS Lyon and Essilor.

For more information: Mathym

Innovation Fund Investment

The Innovation Fund invested alongside Octalfa, Kreaxi and two business angels to support the industrialization of the technology and the marketing of Mathym’s first product

Aerosint – Sold to Desktop Metal – June 24th, 2021

Sector
Materials Technology
Line of Business
3D Printing/additive manufacturing
Founders
M4ke.it, Matthias Hick, Edouard Moens, Kevin Eckes
Registered Office
Rue d'Abhooz 31
4040 Herstal
Belgium

Aerosint is working on an industrial prototype that improves the material efficiency of SLS 3D printing. Aerosint is collaborating with a number of blue chip companies to bring multimaterial 3D printing to the market.

For more information: Aerosint

Innovation Fund Investment

The Innovation Fund invested alongside Noshaq to support the move from proof of concept to industrial prototype.

Proceedix

Sector
Processes, Information Technology
Line of Business
Procedures, work instructions and checks made paperless and mobile
Founders
Peter Verstraeten, Steven Serneels
Registered Office
Heidebergen 20
9830 Sint-Martens-Latem

Proceedix develops, markets and sells a digital solution to enable procedures, work instructions and checks to be carried out paperless and mobile. The software allows to very easily transform paper instructions into a set of digital instructions. The level of details of the various steps can be adjusted by the operator according to his/her level of experience and/or comfort.

Proceedix works best as a cloud solution and is tailored for visualisation on desktops, laptops, phones, tablets or smartglasses.

For more information: Proceedix

Innovation Fund Investment

The Innovation Fund invested together with Saffelberg Investments, Pentacon and the management to fund the go to market.

Iristick

Sector
Processes, Information Technology
Line of Business
Wearables
Registered Office
Lamorinierestraat, 123
2018 Antwerpen

Iristick designs smartglasses for the industry. The Iristick qualifies as safety glasses, can be fitted with prescription glasses and allows the user to handle complex tasks while communicating hands-free, getting instant access to information and sharing data with other operators.

For more information: Iristick

Innovation Fund Investment

The Innovation Fund partnered with Saffelberg Investments, Pentacon and the management to fund the commercial launch of Iristick.

AllerInvest

Sector
Biosciences
Line of Business
Allergies
Founders
Anne-Catherine Mailleux, Pierre Buffet
Registered Office
Clos Chapelle aux Champs 30
1200 Bruxelles

AllerInvest commercialises through pharmacists a kit to prevent allergies to dustmites. The regular application of the treatment to the bedding reduces the allergic response of the patient and allows him or her to sleep much better.

For more information: Acar’up

Innovation Fund Investment

The Innovation Fund invested alongside Inventures, Theodorus and My Micro Invest to fund the commercial expansion of Acar’Up.

Blue Foot Membranes

Sector
Materials Technology/circular economy
Line of Business
Back washable flat sheet membrane
Founders
Patrick Vanschoubroek, VITO
Registered Office
Gerard Mercatorstraat 31
3920 Lommel

Blue Foot Membranes is a scale-up company which provides water-intensive industries with the technology to reuse water.
IPC™ membranes are the worlds first fully back washable flat sheet membranes. Installed in existing as well as in new membrane bioreactor, IPC™ membranes can double the output capacity per square meter and lower the aeration cost by at least 50% of your existing or future MBR.

For more information: Blue Foot Membranes

Innovation Fund Investment

The Innovation Fund invested with LRM, Qbic and Dow to finance the industrialisation of the production and the commercial roll out of the IPC™ membrane.

Rein4ced

Sector
Materials Technology
Line of Business
Reinforced carbon fibres
Founders
Michael Callens and Niels De Greef
Registered Office
Diependaalweg 4a
3020 Winksele
Belgium
REIN4CED will manufacture impact-resistant and lightweight bicycle frames for bicycle brands wishing to offer their cyclists maximum performance with enhanced safety and durability. Carbon fiber composites, known from Formula 1 and race bikes, are light and strong but face sudden, brittle and dramatic fracture behavior. To tackle this problem, REIN4CED has developed and patented a brand new composite material. With this new material, and a completely new fully automated production process, REIN4CED will offer safe, durable and lightweight bicycle frames. The initial focus is on the bicycle market, followed by automotive and aerospace.
For more information: Rein4ced

Innovation Fund Investment

The Innovation Fund invested with Gemma Frisius and Finindus to finance the validation of a full bicycle frame, the industrialisation of the production and the commercial roll out of Rein4ced’s new material.

TheraVet

Sector
Biosciences
Line of Business
Veterinary products
Founders
Enrico Bastianelli
Registered Office
Rue Auguste Piccard 48
6041 Charleroi
Belgium

TheraVet  is a biotech start-up company, created in November 2017 which develops innovative treatments for high unmet medical need osteoarticular conditions (e.g. bone, joint, tendon/ligament) for small companion animals such as dogs. TheraVet’s mature product portfolio is composed of innovative synthetic, biological and cellular products developed from clinical stage and marketed human products.

 

Innovation Fund Investment

The Innovation Fund invested together with Theodorus III, InvestSud affiliates and business angels in TheraVet to fund the execution of clinical trials and move the veterinarian products in development closer to market.

Zeopore Technologies

Sector
Materials Technology
Line of Business
Catalysts
Founders
Danny Verboekend, Martin d'Halluin, Bert Sels, Bert Lagrain, Carl Van Camp
Registered Office
Lelielaan 4, 3061 Leefdaal (Bertem)

Zeopore Technologies NV is a start-up company developing and commercialising a unique and proprietary zeolite “mesoporisation” technology, that significantly improves their efficiency in catalytic refining and petrochemical processes. Its key differentiator is the ability to retain the intrinsic properties of the zeolite, while performing the “mesoporisation” via an industrially and economically viable process.

The main benefits are a higher output of desired chemical products, combined with a lower energy and raw materials consumption, leading to a significantly better performance of the customers production process.

 

For more information: www.zeopore.com

Innovation Fund Investment

The Innovation Fund and Gemma Frisius fund invested in Zeopore to finance the piloting and scale up of Zeopore’s “mesoporisation” technology. The technology will allow chemicals and petrochemical companies to improve their production yields, resulting in better usage and higher transformation efficiency of raw materials.

Univercells

Sector
Biosciences
Line of Business
Biologicals manufacturing technologies and production
Founders
Jose Castillo and Hugues Bultot
Registered Office
Rue Auguste Picard 48
6041 Gosselies
Belgium

Univercells is a technology company delivering novel biomanufacturing platforms to make biologicals available and affordable to all.

Univercells provides customisable solutions for viral production (human and veterinary vaccines, gene therapy vectors, oncolytic viruses), biosimilar monoclonal antibodies and enzyme replacement therapies.

The technology aims to significantly reduce the infrastructure footprint to offer cost-effective production of high-quality biologicals for small to medium size markets.

For more information: http://www.univercells.com

Innovation Fund Investment

The Innovation Fund invested together with Global Health Investment Fund, Korea Investment Partners, Inventures II and TheClubDeal to fund the development of two public health vaccines and the commercialisation of of a diversified portfolio of technology solutions.

Aloxy

Sector
Processes, Information Technology
Line of Business
Industrial process analysis, monitoring and prediction application
Founders
Maarten Weyn, Jan Coppens, Carl Stevens and Glenn Ergeerts
Registered Office
The Beacon
Sint-Pietersvliet 7
2000 Antwerp
Belgium

Aloxy offers a modular IIoT platform for the process and chemical industry.

Aloxy provides tools to improve safety and efficiency, automate processes and to deliver actionable insights into industrial operations.

The initial product line consists of a wireless position sensor for manual valves and a platform to monitor the status of assets during shutdowns and regular maintenance.

Aloxy is a spin-off of imec and University Antwerp.

For more information: http://www.aloxy.io

Innovation Fund Investment

The Innovation Fund invested together with Qbic, Cronos, Engie Fabricom and University Antwerp to help transform the proof of concept into roll outs and secure Atex certification for the sensor as well as fund the development of new applications.

Circular Organics

Sector
Circular economy
Line of Business
Transformation of organic waste into protein, oil and chitin
Founders
Johan Jacobs
Registered Office
Registerde Office in Belgium:

Slachthuisstraat 120/6, 2300 Turnhout
Circular Organics has proven at small size mastering the technology for the transformation, through the black soldier fly, of organic waste into valuable nutrients for animals and products for the chemical industry.
In December 2018, insect technology pioneer AgriProtein, named as one of TIME magazine’s Top 50 Genius Companies, has agreed to a friendly take-over of Circular Organics.
AgriProtein will start financing the first full-scale factory in Belgium in 2019.
For more information: www.agriprotein.com

Innovation Fund Investment

Innovation Fund has invested in Millibeter prior the takeover by AgriProtein, to strengthen the position of Belgium in the worldwide group. A second Belgian plant and the European R&D centre will be established in Belgium in the coming years.

Daphne Technology

Sector
Processes, Circular economy
Line of Business
Emissions control technology
Founders
Mario Michan, Bjorn Asplind, EPFL
Registered Office
Chemin de la Venoge 7
CH-1025 Saint-Sulpice, Vaud
Switzerland

Daphne Technology SA is a spin-off from The École polytechnique fédérale de Lausanne (EPFL) incorporated in 2017 with headquarters at the EPFL Innovation Park.

Daphne’s technology is being developed with support from the Swiss Plasma Center and the European Center for Nuclear Research (CERN). Daphne is currently industrializing its technology in collaboration with a leading European shipping company and expects to start marketing its scrubbers in 2019.

Daphne’s technology transforms air pollutants into valuable by-product, reducing operating expenses in a sustainable manner.

 

Innovation Fund Investment

The Innovation Fund invested together with Saudi Aramco Energy Ventures and a number of private investors in Daphne on December 20th, 2018. The investment will help Daphne get certification of its scrubber.

DoseVue

Sector
Medical devices
Line of Business
Dosimtery equipment for cancer therapy
Founders
Emiliano d'Agostino, SCK-CEN
Registered Office
Agoralaan Abis
3590 Diepenbeek

DoseVue was established in 2013 as a spin-off company of the Belgian Nuclear Research Centre (SCK-CEN) with the aim of developing innovative technologies for convenient and accurate quantification of irradiation doses in the course of medical interventions.

For more information: www.dosevue.com

Innovation Fund Investment

In December 2018, The Innovation Fund participated to a financing round togheter with SCK-CEN and Limburgse Reconversie Maatschappij (LRM). This round aimed at financing its next stage of product development. As a result of the Innovation Fund owns c. 28% of DoseVue

PurVer

Sector
Circular economy
Line of Business
Organic waste processing; production of Vermicompost and biostimulants
Founders
Jean-Pierre Tondreau, Beaudouin de Selliers & Gembloux Agrobiotech
Registered Office
2 Passage des Déportés
5030 Gembloux
Belgium

PurVer produces and sells vermicompost and derived products. PurVer is to become the European leader in that market.

 

For more information: www.PurVer.be

Innovation Fund Investment

Innovation Fund invested in PurVer alongside S.R.I.W. Environnement and CFEP to accelerate the investments and the growth of this capital intensive business en bring it to the level of profitability.

Graftys

Sector
Biosciences
Line of Business
Bone cements
Founders
Aurelien Valet, Sebastien Genesta
Registered Office
415, rue Claude Nicolas Ledoux
13854 Aix-en-Provence

Graftys develops, manufactures and markets patented synthetic orthopedic biomaterials, in particular a new generation of resorbable calcium-phosphate cements for reconstructive surgery. The bone cement market is one of the fastest growing sgements of the orthopedic market. The company’s key products are commercialised in more than 25 countries, including Europe and the United States of America.

For more information: www.Graftys.com

Innovation Fund Investment

In February 2019, Innovation Fund participated in a €4,1m financing round with Noshaq, Go Capital and TheClubDeal.
In November 2021, Graftys SA acquired Biologics4Life, a French company which is developing a new generation of injectable synthetic bone graft materials.  This combination will strengthen cross-functional capabilities in R&D, manufacturing, regulatory affairs, and global commercialisation. To achieve its new development and commercial ambitions, Graftys raised €2,6M from Innovation Fund, Go Capital, Noshaq and other European investors.

Tools4Patient

Sector
Biosciences
Line of Business
Individual patient response characterisation in clinical research
Founders
Dominique Demolle, Alvaro Pereira and Chantal Gossuin
Registered Office
11 Rue Granbonpré
1348 Louvain-La-Neuve

Tools4Patient addresses the interferences caused by individual response in new therapies clinical research. Its objective is to reduce the failures of clinical tests due to placebo effect, hence reducing the cost of clinical research.

Placebell is the first product marketed.

For more information: Tools4Patient

Innovation Fund Investment

Together with Sambrinvest, Innovation Fund invested in Tools4patient in April 2019.

Apaxen

Sector
Biosciences
Line of Business
Pre-clinical stage biotechnology
Founders
Gael Jalce (PhD), based on a patent co-developed with INSERM and Paris-Sud University
Registered Office
Brussels South Charleroi Biopark
Rue Adrienne Bolland 8
6041 Charleroi
Belgium

Apaxen is a preclinical stage biotechnology company developing unique anti-inflammatory therapeutics with a primary focus on pulmonary arterial hypertension (PAH). It developed a first-in-class small molecule inhibitors of pleiotropic pro-inflammatory cytokine “Macrophage migration Inhibitory Factor (MIF)”, a crucial regulator of innate immune responses. Apaxen’s lead compound MFC-1040 has a unique mechanism of action and has the potential to revolutionise the standard of care of PAH and other diseases related to chronic inflammation.

For more information: Apaxen

Innovation Fund Investment

In July 2019, The Innovation Fund participated to a €3.3 million in a Series A funding round together with Theodorus, Sambrinvest, Innovation Fund, Financière Spin-off Luxembourgeoise and members of “Be Angels”. As a result of the Innovation Fund owns c. 13%.

Norimat

Sector
Materials Technology
Line of Business
Spark Plasma Sintering process
Founders
Romain Ephere and Yannick Beynet
Registered Office
51 rue de l'innovation
31670 Labège (Toulouse)
France

Created in 2016, Norimat has developed an innovative over-moulding process based on Spark Plasma Sintering technology (SPS). The company uses breakthrough technology developed by the CIRIMAT laboratory (CNRS Toulouse).

The company currently exploits five different patents. All these skills around the SPS process are sold to clients in the aeronautics, aerospace, defence or luxury industry.  In Europe, Norimat is the first player to bring out SPS flash sintering “from the laboratory” to a industrial level.

For more information: Norimat

Innovation Fund Investment

In July 2019, The Innovation Fund participated to a Series A funding round together with Galia Gestion and IRDI SORIDOC Gestion. As a result of the Innovation Fund owns c. 12% of the company.

Secoya Technologies

Sector
Process Technology
Line of Business
Continuous productions technologies for the pharmaceutical sector
Founders
Pr. Benoit Scheid, Adrien Dewandre, Youen Vitry, Jean Septavaux, Bart Rimez, Olivier André
Registered Office
Fond des Més 4,
1348 Ottignies-Louvain-la-Neuve
Belgium

Secoya Technologies is a spin-off of ULB. It has a portfolio of 4 technologies covering the key steps of the drug production process: continuous reactions, crystallisation, pervaporation and droplet generation.

The unique value proposition of Secoya is to:

(i) bring down these unit operations at the sub-millimetric scale to take benefit of a rigorous control of the operating conditions;

(ii) rely on continuous processing and smart scale-up to ensure production rates compatible with industrial needs; and

(iii) offer 4 complementary technologies.

Secoya will develop more synergies between the different steps.

Innovation Fund Investment

On 22 November 2019, Innovation Fund together with private investors invested 1.050.000 € in Secoya Technologies, joining ULB and the founders in the capital. Proceeds will be used to launch the company.

Fluigent

Sector
Process Technology
Line of Business
Microfluidics
Founders
Jean-Louis Viovy and Jacques Lewiner
Registered Office
67 Avenue de Fontainebleau
94270 Le Kremlin-Bicêtre
France

Fluigent is a French company leader in controlling accurately pressure and flow in multiple channel chips. Fluigent was the first company to introduce pressure pumps to the microfluidic research market, as opposed to conventional syringe pumps. Today, Fluigent develops, manufactures and supports the most advanced microfluidic full pressure and flow-rate control systems available, designed for coupled multi-channel configurations.

More information: Fluigent

 

Innovation Fund Investment

In November 2019, The Innovation Fund participated in a funding round with Inventures. As a result, The Innovation Fund owns c. 6% of the company.

Spentys

Sector
Medical devices
Line of Business
Scanning, modelling and 3D-printing of splints and casts
Founders
Louis-Philippe Broze and Florian De Boeck
Registered Office
120 rue Saint-Denis,
1190 Forest
Belgium

Created in 2017, Spentys develops an interactive 3D-printing and 3D modelling platform (SaaS) that allows medical practitioners to design tailor made immobilisation devices, replacing splints or casts. It reduces the gap between 3D technologies and the practitioners’ medical environment. The orthopaedic device, called Polycast, is produced in 3 steps: 3D scan of the patient’s limb, 3D model of the specific device, 3D print onsite or in a Spentys production facility.

The final product considerably improves the quality of life for patients as it is tailor made, waterproof, light, aerated and recyclable.

More info: www.spentys.com

Innovation Fund Investment

On March 17th, 2020, IF invested 518 kEUR in Spentys, in a capital increase of 1,7 Mo € together with SRIB, Sambrinvest & individuals, for a share of 10% of the capital.
Proceeds will be used to launch pilot cases in hospitals for traumatic pathologies, where immobilisation is needed immediately, to expand the solution for chronic pathologies and to further develop the software.

OUAT!

Sector
Processes, Information Technology
Line of Business
Industrial processes conception, asset management, training
Founders
Matthieu Egloff and Nicolas Vertommen
Registered Office
Rue d'Alost 7
1000 Brussels
BELGIUM

OUAT! aims to facilitate the digital transformation of the life sciences industry. In increasingly intelligent and connected factories, OUAT! enables the men and women of the biopharmaceutical industry to achieve operational excellence using virtual reality technologies.

HakoBio, the intuitive 3D platform of OUAT! enables to create and operate the digital twin of a factory and to achieve operational excellence throughout its life cycle. This platform is dedicated to the biopharmaceutical industry and contains a database of more than 1000 specific equipments. It brings a gain in time and efficiency in the development of a production chain. It is used for planning and visual simulation of processes, for immersive learning and for interactive, simplified and centralized data management.

OUAT! is supported by the Brussels Region (hub.brussels, Innoviris, SRIB), the Innovation Fund, the European Commission and My Innovation Center.

For more information: http://hakobio.com

 

Innovation Fund Investment

Innovation Fund invested EUR 500k in OUAT! on December 3rd, 2020 to fund the further development of HakoBio and the roll out of the software to new clients.

TimeSeer.AI

Sector
Processes, Information Technology
Line of Business
Data Analytics

In stealth mode

Axinesis

Sector
Medical devices
Line of Business
Neurorehabilitation of the upper limb for patients suffering from brain injuries
Founders
Julien Sapin
Registered Office
Avenue Sabin 3
B - 1300 Wavre
 
Axinesis is a spin-off from the Université catholique de Louvain (UCL, Belgium), which carries the mission to improve the functional recovery of patients through innovative and accessible technologies dedicated to the rehabilitation of the upper limbs of patients suffering from stroke or children with cerebral palsy.

Axinesis has 3 CE-marked devices in its portfolio:

REAplan is an end-effector robot, offering more than 1.000 movements per hour, for use in hospitals and intensive rehabilitation centers in the days and weeks following the brain injury.

REAtouch is an intensive functional rehabilitation device, stimulating bimanual rehabilitation. Its use is foreseen for the weeks following the intensive rehabilitation.

REAtouch Lite completes the product portfolio with a device to be used at home.

The three devices are linked with a software which allows a ludic rehabilitation for the patients and an easy follow up for the therapists.

For more information : Axinesis

 

Innovation Fund Investment

On December 14th, 2020, Innovation Fund invested 550 k€ in Axinesis, together with VIVES, W.I.N.G. and NivelInvest. The funds will be used to expand in Europe and to launch of REAtouch Lite, the first B2C product.

HOME EOS

Sector
Materials Science
Line of Business
Natural acoustic and thermal insulation materials
Founders
Pierre Pouppez de Kettenis
Registered Office
HOME EOS sa/nv
rue de Fontenelle, 2
B-6240 Farciennes

T + 32 (0) 71 37 63 80

Thanks to its highly innovative Stop Sound technology, awarded “Solar Impulse Efficient Solution” and “Greenov”, Home Eos produces mass loaded membranes in viscoelastic biobased polymers. Those noise barriers provide high performance in terms of acoustic insulation, vibration dampening and fire resistance. Key end-markets are transport, construction and industry.

Innovation Fund Investment

In March 2021, Innovation Fund invested in HomeEos together with 6K Venture (Sambrinvest) and W.I.N.G. The funds will be used to scale-up the production capacity and commercial development.

TERAKALIS

Sector
Process Technology
Line of Business
Inspection of internal defects and characterisation of material’s physical and chemical properties.
Founders
Thierry Antonini and Christophe Archier
Registered Office
256, rue de Thor
34000 Montpellier
FRANCE

Leveraging a new domain of electromagnetic waves – T-rays (TeraHertz) – and a breakthrough technological innovation from collaboration with the CNRS in Montpellier, Terakalis designs and manufactures generic and custom-made products/system for analysis and control in the heart of the material. Their business is the inspection of internal defects and the characterisation of the material’s physical and chemical properties.

Innovation Fund Investment

On October 28th, 2021, Innovation Fund participates in a stock offering together with Supernova, Galia Gestion, Aster and CFEP. This €3,2M funding round will be used accelerate commercial and international development of the company.

VOCSens

Sector
Process Technology
Line of Business
Gas & environmental sensing solutions at low cost
Founders
Thomas Walewyns & Yann Danlée
Registered Office
Rue Louis de Geer, 6
1348 Ottignies-Louvain-la-Neuve
Belgium

Vocsens is a spin-off of UCL, which develops a disruptive gas & environmental sensing solution providing highly reliable and qualified data (selectivity and specificity), at a very low cost. The solution increases autonomy, both in terms of remote calibration/maintenance and reduced power consumption (> 5 – 10 years). The objective is to produce gas sensors which can detect up to 16 different gasses (besides temperature & humidity), 50 times cheaper, 100 times smaller and 1000 times less consuming than current gas and environmental sensors.

For more information : www.vocsens.com

 

Innovation Fund Investment

On September 24th, 2021, InnovationFund invested in VocSens together with Vives, InvestBW, W.IN.G (SRIW) and Industrya. Split in 3 phases, the commitment of the consortium amounts to €2,5m.

SATURNE TECHNOLOGY

Sector
Process Technology
Line of Business
Additive Manufacturing
Founders
Water Grzymlas
Registered Office
2 rue de l'Etang
5326 Contern
Luxembourg

Saturne Technology is a subcontractor of blue-chip industrial companies (Alstom, Safran, Alfa Laval…) for the Additive Manufacturing (AM) of high-quality metal parts. Saturne covers the whole process, from the selection of materials to the delivery of the finished products to the customer.

Innovation Fund Investment

On December 16th, 2021, Innovation Fund invested €1m in Saturne with Akiles, Eurefi and Fonds Européen des Matériaux to accelerate the growth of Saturne Technologies in 3D printing of complex parts for industrial sectors: aeronautics, spatial, automotive…

SENSEin

Sector
Process Technology
Line of Business
Non-intrusive sensors for composite materials
Founders
Jean-Claude Lenain
Registered Office
Espace Teknica
Parc Technologique de Soye
4 rue Galilée
56270 Ploemeur
FRANCE

SENSE in® develops and markets innovative monitoring solutions of composite parts based on non-intrusive resistive sensors integrated into the heart of composite structures during their manufacturing process.

Innovation Fund Investment

On March 3, 2022, Innovation Fund joined Go Capiral, SFLD and Crédit Agricole in the capital of SENSEin in SENSE in

LiveDrop

Sector
Process Technology
Line of Business
Droplets microfluidics
Founders
Stéphanie Van Loo & Geoffrey Holsbeek
Registered Office
Giga B34
Av. de l'hôpital 11
Liège 4000
Belgium

Modaflow, the flow cytometer based on droplet microfluidics

Droplet microfluidics is a powerful technology that help researchers analyze multiple or single cells, bacteria, particles and biological material quicker and more effectively that traditional methods.

Innovation Fund Investment

On May 25th, 2022, IF invested 500.000€ in a tour of €1,4m, together with Noshaq, W.I.N.G., Trasis and Frédéric Martial, for a share of 17,2% non diluted (15,4% fully diluted) in LiveDrop.

KEEY AEROGEL

Sector
Materials technology
Line of Business
Aerogel producer and technology provider
Founders
Francisco Ruiz
Registered Office
203 Rue du Général de Gaulle
68440 HABSHEIM (France)

Keey Aerogel aims at becoming the European leader in the production of high-quality aerogels(1), at low price (-40% to -70% compared to present market prices), and with a low carbon footprint. The company patented a continuous production process of aerogels and the use of construction waste as a raw material, replacing silica.

Innovation Fund Investment

On June 29th, 2022, IF invested 750.000€ in a tour of €1,5m, together with Capital Grand Est for a share of 9,4% non diluted (8,0% fully diluted) in Keey Aerogel